Lv2
150 积分 2022-03-02 加入
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial
2天前
已完结
Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial
2天前
已完结
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications
2个月前
已完结
Evidence-based guidelines for the pharmacological treatment of migraine, summary version
2个月前
已完结
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine
2个月前
已完结
Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives
3个月前
已完结
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
3个月前
已完结
Sex differences in CGRP-induced vasodilation of human middle meningeal arteries but not human coronary arteries: implications for migraine
3个月前
已完结
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
3个月前
已完结
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trials
3个月前
已完结